Wednesday, July 8, 2026

pharma · COVID-19 · Hepatitis C · AVIR

Atea Pharmaceuticals

Atea Pharmaceuticals trial registry — 40 ClinicalTrials.gov studies with program phase, status, and indication context.

225 Franklin St, Suite, 2100, Boston, Massachusetts 02110, US HQ
2014 Founded
57 Employees
Public company Type
AVIR · NYSE Ticker
Company details
Status
Public
HQ
225 Franklin St, Suite, 2100, Boston, Massachusetts 02110, US
Founded
2014
Employees
57
Programs
37
Drugs
29
Patents
35
Intelligence · Clinical Trials

Atea Pharmaceuticals clinical trials

Registry index of 40 ClinicalTrials.gov studies linked to Atea Pharmaceuticals programs — each row shows trial ID, program name, phase, status, and indication.

Atea Pharmaceuticals trial registry — 40 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

8 updates

Latest clinical program signals indexed for Atea Pharmaceuticals.

  1. AT-01B-008 — Phase 3

    Clinical update
  2. AT-01B-006 — Phase 1

    Clinical update
  3. Treatment A-Bemnifosbuvir/Ruzasvir FDC administered fasting — Phase 1

    Clinical update
  4. GHB04L1 — Phase 1

    Clinical update
  5. Ethinyl Estradioll/Levonorgestrel (EE/LNG) — Phase 1

    Clinical update
  6. Buprenorphine/Naloxone + BEM/RZR — Phase 1

    Clinical update
  7. Bemnifosbuvir (BEM) — Phase 3

    Clinical update
  8. Bemnifosbuvir (BEM)/Ruzasvir (RZR) FDC under fasting conditions — Phase 1

    Clinical update

Trial registry

40 studies